ASLAN
LIVE

Serial Number

79316435

Owner

ASLAN Pharmaceuticals Pte. Ltd.

Attorney

Andrew D. Dorisio

Filing Date

Jun 24, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ASLAN Trademark

Serial Number: 79316435 • Registration: 6868318

ASLAN is a trademark filed by ASLAN Pharmaceuticals Pte. Ltd. on June 24, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ASLAN Pharmaceuticals Pte. Ltd.

83 CLEMENCEAU AVENUE,

Entity Type: 24

Trademark Details

Filing Date

June 24, 2021

Registration Date

October 11, 2022

Published for Opposition

July 26, 2022

Goods & Services

Pharmaceutical preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases and disorders, dermatological diseases and disorders, damaged skin, hair and tissues, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, respiratory diseases and disorders; medical preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases and disorders, dermatological diseases and disorders, damaged skin, hair and tissues, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, respiratory diseases and disorders; veterinary preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases and disorders, dermatological diseases and disorders, damaged skin, hair and tissues, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, respiratory diseases and disorders; sanitary preparations for medical purposes; dietetic food adapted for medical or veterinary use; food for babies; dietary supplements for humans and animals

Scientific and technological services, namely, research and design in the field of medicines, pharmaceutical preparations, cosmetic preparations, dermatological preparations, biotechnological preparations, biological preparations, dietetic substances and chemical preparations for medical, veterinary, sanitary, bacteriological, pharmacological and genealogical use; research and development of new products in the field of medicines, pharmaceutical preparations, cosmetic preparations, dermatological preparations, biotechnological preparations, biological preparations, dietetic substances and chemical preparations for medical, veterinary, sanitary, bacteriological, pharmacological and genealogical use; scientific research in the nature of conducting clinical trials

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Aug 7, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Apr 25, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 20, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 30, 2023 FICS
FINAL DISPOSITION PROCESSED
Jan 30, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 11, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 11, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 11, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 26, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 26, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Jul 25, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 6, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 6, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 6, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 23, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 15, 2022 TROA
REFUSAL PROCESSED BY IB
May 24, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 4, 2022 RFCS
REFUSAL PROCESSED BY MPU
May 4, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 23, 2022 RFCR
NON-FINAL ACTION WRITTEN
Mar 22, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 16, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 3, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 30, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 29, 2021 REPR